activity Yale Cancer Center Protocol Review Committee (PRC)
2022 - Presentactivity Yale Affiliated Hospitals Program (YAHP)-Hematology
2022 - Presentactivity New England Hematologic Malignancies Symposium
07/01/2023 - Presentactivity British Journal of Hematology
10/01/2015 - Presentactivity Bone Marrow Transplantation
10/01/2015 - Presentactivity Clinical Lymphoma Myeloma and Leukemia
10/01/2017 - Presentactivity Cancer Journal
10/01/2021 - Presentactivity The DeLuca Center for Innovation in Hematology Research Seminar Series
2023 - Presentactivity HIV-Cancer Focus Group
2022 - Presentactivity HemOnc.org Aggressive Lymphomas Section
2019 - Presentactivity “ASCO Reading Room" section of MedPage Today
2023 - Presentactivity American Society of Hematology
2014 - Presentactivity American Society of Cancer Oncology
2014 - Presentactivity : Clinical Correlates of Response with Mogamulizumab in MF/SS: Skin Flare and Lymphopenia
activity Efficacy and Safety of EPOCH in Aggressive T-Cell Lymphomas- A Real World Analysis
activity T-Cell Lymphoma Case Presentation
activity Efficacy and Safety of EPOCH in Aggressive Presentations of Cutaneous T-Cell Lymphomas
activity American Society of Hematology Annual Meeting 2021
Session Name: 624. Hodgkin Lymphomas and T/NK cell Lymphomas: T/NK Cell Lymphoma Relapsed Therapy Session Date: Monday, December 13, 2021 Session Time: 10:30 AM - 12:00 PM Eastern time Room: Georgia World Congress Center, Hall A12021 - 2021activity Advances in Treatment of Primary Central Nervous System Lymphoma
activity Beyond Chemotherapy: Novel Approach to Treatment of Primary Central Nervous System Lymphoma